Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2016 June;151(3) > Giornale Italiano di Dermatologia e Venereologia 2016 June;151(3).244-50





Rivista di Dermatologia e Malattie Sessualmente Trasmesse

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014




Giornale Italiano di Dermatologia e Venereologia 2016 June;151(3).244-50

lingua: Inglese

Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40

Arzu ATASEVEN 1, Recep KESLI 2

1 Department of Dermatology, Konya Training and Research Hospital, Konya, Turkey; 2 Department of Microbiology, Afyon Kocatepe University Faculty of Medicine, Afyonkarahisar, Turkey


BACKGROUND: Psoriasis is a chronic relapsing inflammatory skin disease. Vaspin, vascular adhesion protein-1 (VAP-1), chitinase-3-like protein 1 (also known as YKL-40), and high-sensitivity C-reactive protein (hs-CRP) are inflammatory biomarkers. However, with the exception of hs-CRP, the role of these markers in the pathogenesis of psoriasis is yet to be elucidated. This study investigated vaspin, VAP-1, YKL-40, and hs-CRP levels in the serum of psoriatic patients and healthy controls.
METHODS: A total of 56 patients suffering from psoriasis and 34 age-matched controls were included in the study. Vaspin, VAP-1, YKL-40, and hs-CRP serum levels were evaluated by ELISA. The psoriasis area severity index (PASI) was calculated in all psoriatic patients and patients were divided in two groups according to PASI <10 or ≥10.
RESULTS: The serum concentration of soluble vaspin was significantly lower in psoriatic patients compared to healthy controls (1.33±0.32 pg/mL, 1.72±0.39 pg/mL, respectively; P<0.001). The serum concentrations of soluble VAP-1 and hs-CRP were significantly higher in psoriatic patients compared to healthy controls (VAP-1: 2.05±0.46 pg/mL, 1.82±0.46 pg/mL, hs-CRP: 4.97±3.53 mg/L, 3.48±0.08 mg/L, respectively; P<0.05). There was no significant difference in the serum concentration of soluble YKL-40 between psoriatic patients and the control group (1.37±0.55 ng/mL, 1.54±0.79 ng/mL, respectively; P>0.05). The mean PASI score was 9.1±8.2 in the patient group. A total of 36 patients had PASI<10 and 20 patients had PASI≥10. The serum concentration of vaspin was the only marker to exhibit a significant difference between the low and high PASI groups (1.40±0.27 pg/mL and 1.20±0.37 pg/mL, respectively; P<0.05).
CONCLUSIONS: These findings suggest that vaspin and VAP-1 may play a role in the pathogenesis of psoriasis and can be used as markers of the disease. Furthermore, vaspin levels may reflect the severity of disease.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail